Ilex Medical Stock Beta
| ILX Stock | 6,782 80.00 1.19% |
Ilex Medical fundamentals help investors to digest information that contributes to Ilex Medical's financial success or failures. It also enables traders to predict the movement of Ilex Stock. The fundamental analysis module provides a way to measure Ilex Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ilex Medical stock.
Ilex |
Ilex Medical Company Beta Analysis
Ilex Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Ilex Medical Beta | -0.11 |
Most of Ilex Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ilex Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Ilex Medical has a Beta of -0.1061. This is much lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The beta for all Israel stocks is notably higher than that of the company.
Ilex Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ilex Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ilex Medical could also be used in its relative valuation, which is a method of valuing Ilex Medical by comparing valuation metrics of similar companies.Ilex Medical is currently under evaluation in beta category among related companies.
As returns on the market increase, returns on owning Ilex Medical are expected to decrease at a much lower rate. During the bear market, Ilex Medical is likely to outperform the market.
Ilex Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 901.49 M | |||
| Shares Outstanding | 11.19 M | |||
| Shares Owned By Insiders | 62.44 % | |||
| Shares Owned By Institutions | 10.16 % | |||
| Price To Book | 1.83 X | |||
| Price To Sales | 1.16 X | |||
| Revenue | 1.06 B | |||
| Gross Profit | 379.38 M | |||
| EBITDA | 307.85 M | |||
| Net Income | 197.48 M | |||
| Cash And Equivalents | 118.65 M | |||
| Cash Per Share | 11.80 X | |||
| Total Debt | 1.28 M | |||
| Debt To Equity | 38.00 % | |||
| Current Ratio | 1.75 X | |||
| Book Value Per Share | 51.14 X | |||
| Cash Flow From Operations | 270.68 M | |||
| Earnings Per Share | 9.75 X | |||
| Number Of Employees | 254 | |||
| Beta | -0.11 | |||
| Market Capitalization | 1.01 B | |||
| Total Asset | 875.07 M | |||
| Annual Yield | 0.06 % | |||
| Five Year Return | 2.47 % | |||
| Net Asset | 875.07 M | |||
| Last Dividend Paid | 5.32 |
About Ilex Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ilex Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ilex Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ilex Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ilex Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Ilex Stock analysis
When running Ilex Medical's price analysis, check to measure Ilex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilex Medical is operating at the current time. Most of Ilex Medical's value examination focuses on studying past and present price action to predict the probability of Ilex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilex Medical's price. Additionally, you may evaluate how the addition of Ilex Medical to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |